Bitget Becomes First Exchange to Offer All Cryptos on Four Major Chains in One Account 23-09-2025, 20:00

Io Therapeutics, Inc., presented today results from studies of IRX4204, the company’s phase II clinical development stage, highly selective RXR nuclear receptor agonist compound, supporting its potential use for treatment of amyotrophic lateral sclerosis 16-07-2024, 20:26

Recursion Appoints Najat Khan, PhD, as Chief R&D Officer and Chief Commercial Officer 16-04-2024, 19:00